A Phase II Study Of Depsipeptide In Patients With Relapsed Or Refractory Ovarian Carcinoma
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 31 Jan 2013
At a glance
- Drugs Romidepsin (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 31 Jan 2013 Status changed from suspended to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 26 Jan 2010 Status changed from completed to suspended as reported by ClinicalTrials.gov.